Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
Protalix BioTherapeutics, Inc. (PLX)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
09/29/2023Boudes Pol FDirectorGrantStock Options (Right to Buy)61.7k$1.66$102.4k 09/29/2023
09/29/2023Melincoff Gwen ADirectorGrantStock Options (Right to Buy)61.7k$1.66$102.4k 09/29/2023
09/29/2023Bar-Shalev AmosDirectorGrantStock Options (Right to Buy)61.7k$1.66$102.4k 09/29/2023
09/29/2023Ben Zvi ShmuelDirectorGrantStock Option (Right to Buy)61.7k$1.66$102.4k 09/29/2023
09/29/2023Schwartz AharonDirectorGrantStock Option (Right to Buy)61.7k$1.66$102.4k 09/29/2023
08/15/2023Naos YaronSr. VP, OperationsGrantCommon Stock187.3k$0.00$0By Trust08/15/2023
08/15/2023Hayon YaelVP, Research & DevelopmentGrantCommon Stock35.1k$0.00$0By Trust08/15/2023
08/15/2023Hayon YaelVP, Research & DevelopmentGrantStock Options (Right to Buy)35.1k$1.99$69.9k 08/15/2023
08/15/2023Bashan DrorPresident and CEOGrantCommon Stock800k$0.00$0By Trust08/15/2023
08/15/2023Rubin EyalSr. VP and CFOGrantCommon Stock201.9k$0.00$0By Trust08/15/2023
01/03/2023Schwartz AharonDirectorPurchaseCommon Stock110k$1.42$155.8k 01/03/2023
09/07/2022Bar-Shalev AmosDirectorGrantStock Options (Right to Buy)50k$1.03$51.5k 09/07/2022
09/07/2022Bronfeld ZeevDirectorGrantStock Options (Right to Buy)100k$1.03$103k 09/07/2022
09/07/2022Schwartz AharonDirectorGrantStock Options (Right to Buy)50k$1.03$51.5k 09/07/2022
09/07/2022Boudes Pol FDirectorGrantStock Options (Right to Buy)50k$1.03$51.5k 09/07/2022
09/07/2022Melincoff Gwen ADirectorGrantStock Options (Right to Buy)50k$1.03$51.5k 09/07/2022
09/07/2022Bashan DrorPresident and CEOGrantStock Options (Right to Buy)750k$1.03$772.5k 09/07/2022
09/07/2022Naos YaronSr. VP, OperationsGrantStock Options (Right to Buy)340k$1.03$350.2k 09/07/2022
09/07/2022Ben Zvi ShmuelDirectorGrantStock Options (Right to Buy)10k$1.03$10.3k 09/07/2022
09/07/2022Rubin EyalSr. VP and CFOGrantStock Options (Right to Buy)350k$1.03$360.5k 09/07/2022
09/07/2022Hayon YaelVP, Research & DevelopmentGrantStock Options (Right to Buy)250k$1.03$257.5k 09/07/2022
06/30/2022Ben Zvi ShmuelDirectorGrantStock Options (Right to Buy)40k$1.09$43.6k 06/30/2022
04/11/2022Bashan DrorPresident and CEOPurchaseCommon Stock68k$1.50$102k 04/11/2022
02/25/2022Rubin EyalSr. VP and CFOGrantCommon Stock122k$0.00$0By Trust02/25/2022
02/25/2022Bashan DrorPresident and CEOGrantCommon Stock637.5k$0.00$0By Trust02/25/2022
06/03/2021Dexcel Pharma Technologies Ltd.10% OwnerSaleCommon Stock857.5k$2.25$1.9M 06/02/2021
06/02/2021Dexcel Pharma Technologies Ltd.10% OwnerSaleCommon Stock61.2k$2.56$156.6k 06/02/2021
08/11/2020Rubin EyalSr. VP and CFOGrant 246.1k$0.00$0By Trust08/11/2020
08/11/2020Bashan DrorPresident and CEOGrant 447.9k$0.00$0By Trust08/11/2020
08/11/2020Naos YaronSr. VP, OperationsGrantStock Options (Right to Buy)122.7k$3.59$440.3k 08/11/2020
08/11/2020Rubin EyalSr. VP and CFOGrantCommon Stock246.1k$0.00$0By Trust08/11/2020
08/11/2020Bashan DrorPresident and CEOGrantCommon Stock447.9k$0.00$0By Trust08/11/2020
07/05/2020Hayon YaelVP, Research & DevelopmentGrantStock Options (Right to Buy)129.8k$3.73$484k 07/05/2020
06/07/2020Almon Einat BrillSVP, Chief Development OfficerGrantStock Options (Right to Buy)197k$3.59$707.2k 06/07/2020
04/07/2020Schwartz AharonDirectorPurchaseCommon Stock64k$2.43$155.3k 04/07/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy